DSpace Repository

Screening for aminoacidurias and organic acidurias in patients with metabolic or neurological manifestations

Show simple item record

dc.contributor.author Patil, Vidya S.
dc.contributor.author Jailkhani, Rama
dc.contributor.author Trivedi, Dhiraj J.
dc.contributor.author Kulkarni, Shreerang P.
dc.contributor.author Sagare, Aparna A.
dc.contributor.author Mudaraddi, Rakesh
dc.contributor.author Bargale, Anil
dc.date.accessioned 2012-08-31T10:49:12Z
dc.date.available 2012-08-31T10:49:12Z
dc.date.issued 2012-01-17
dc.identifier.citation Biomedical Research. 2012; 23(2): 253-258. en_US
dc.identifier.issn 0970-938X
dc.identifier.uri http://hdl.handle.net/123456789/96
dc.description.abstract Inborn errors of metabolism (IEM) are a group of inherited disorders occurring due to a sin- gle gene defect, resulting in accumulation of an abnormal metabolite leading to varied mani- festations and complications. Early recognition and treatment are the best determinants of outcome in such patients. Objective: With the objective of providing a guide towards early di- agnosis of IEM among patients having strong clinical suspicion, we have screened 128 urine samples from patients with either metabolic or neurological features. Method: Urine samples were analysed for abnormal constituents like reducing sugar, proteins, ketone bodies by rou- tine laboratory chemical tests. Special tests were done for phenylketones, organic acids, keto- acids, tyrosine, mucopolysachharides supported by thin layer chromatography for amino- acidurias. Results: Most common positive tests reported in our study are, non specific general- ized aminoacidurias (58%), branched chain aminoacidurias (14%), tyrosinuria (13%), methlymalonic aciduria (7%) followed by mucopolysaccharidosis (4%) and phenylketonuria (2%). The common clinical manifestations observed among all participants were neurological features like convulsions (25.7%), delayed milestones (17.9%), and followed by metabolic aci- dosis (17.2%) and hypoglycemia (10.1%). Conclusion: High index of suspicion from clinicians supported by preliminary screening tests can aid in early presumptive diagnosis, which helps in initiating early treatment to prevent lethal neurological complications. en_US
dc.language.iso en en_US
dc.publisher Biomedical Research Foundation en_US
dc.subject Aminoacidurias en_US
dc.subject Organic acidurias en_US
dc.subject TLC for aminoacids en_US
dc.subject Urine screening for IEM en_US
dc.subject Abnormal metabolite
dc.subject Neurological complications
dc.subject Inborn error metabolism
dc.title Screening for aminoacidurias and organic acidurias in patients with metabolic or neurological manifestations en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account